Article Archive
CHMP gives nod to four new drugs at meeting
1 December 2008
CHMP denies B-MS and Santhera drugs
1 December 2008
CHMP OKs Novartis
1 December 2008
Resolvyx ready for first ever clinical trial
1 December 2008
Quintiles/SAS' pharma programming course
1 December 2008
Shire's HGT unveils ambitious growth plan, doubling sales contribution to 30% by 2015
1 December 2008
Cinryze achieves 30 min symptom improvement
1 December 2008
Aptima shows higher specificity than Hybrid Capture 2 HPV test
1 December 2008
SCS signs UK stem cell deal with Pfizer
1 December 2008
Resolvyx enters deal with NNRI for resolvin
1 December 2008
Isogen launches first phase of sterile contract facility
1 December 2008
First European Antibiotics Awareness Day
1 December 2008
EMEA maintains negative opinion on Santhera's idebenone
1 December 2008
Neuromed's pivotal Ph III NMED-1077 trial completes enrollment
1 December 2008
Cougar initiates Ph I/II CB7630 trial
1 December 2008
Council to discuss when NICE should consider technology outside cost-effectiveness range
1 December 2008
IMPAX sued by Lilly over Cymbalta
1 December 2008
Barr profit down 21% as it nears Teva merger
1 December 2008
ArQule bailed out of deeper loss by Daiichi
1 December 2008
Perrigo posts record profit and sales
1 December 2008
Novagali withdraws EU Vekacia MAA
1 December 2008
Cephalon swings back to profit in 3rd qtr
1 December 2008
Recruitment setbacks for Ph III defibrotide trial
1 December 2008
Pfizer withdraws OTC Viagra EU application
1 December 2008
FDA clears ImClone's BB50 production unit
1 December 2008
GSK buys AstraZeneca OTC line for $253M
1 December 2008
Major fake drug hauls in France, seized in transit
1 December 2008
LEEM's five-point plan for France's CT future
1 December 2008
GSK takes steps to set up flu JV in China
1 December 2008
AstraZeneca axes jobs, closes plants
1 December 2008
Pharming's Prodarsan completes Ph I trial
1 December 2008
Barr's shareholders approve $7.5B takeover by Teva
1 December 2008
Cellzome gets 3.9M-euro grant from German govt
1 December 2008
Eisai takes Dainippon drug into SE Asia
1 December 2008
MSD publishes strong migraine trial results
1 December 2008
Debiopharm to co-develop painkiller
1 December 2008
MorphoSys signs deal with Galapagos
1 December 2008
Sosei out-licenses mefloquine to Treague
1 December 2008
Study shows no benefit for widely-used pre-term drug
1 December 2008
WHO suggestions for stemming HIV epidemics
1 December 2008
Bayer pays out $97.5M to settle kick-back allegations
1 December 2008
Japan stock market week to Nov 24, 2008
1 December 2008
NICE recommends Roche's Tarceva as Taxotere alternative
1 December 2008
AstraZeneca does deal with Teva over generic Pulmicort
1 December 2008
UPDATE: GPhA welcomes FTC move on biogenerics
1 December 2008
Medicare drug benefit annual enrollment
1 December 2008
US CMS paid $198M for "unapproved" drugs
1 December 2008
US state NC's biotech investment tops $1B
1 December 2008
Labor unions attack Januvia marketing
1 December 2008
Waxman ousts Dingell in US House shift
1 December 2008
EU confirms pharma raids on cartel concerns
1 December 2008
ProStrakan's 10-month sales jump 33%
24 November 2008
AZ sells Swedish facility to Recipharm AB
24 November 2008
Debiopharm files complete response to FDA for Sanvar
24 November 2008
Pfizer to spend $60M on UK stem cell unit
24 November 2008
Ph II study of ImClone's IMC-A12 starts enrolling patients
24 November 2008
Aslan licenses Pharming's lactoferrin
24 November 2008
Solvay discontinues CB1 obesity drug SLV319
24 November 2008
Theravance's telavancin gets nod from FDA advisory panel
24 November 2008
SuperGen promotes David Bearss to CFO
24 November 2008
Middlebrook names five new sales VPs
24 November 2008
IFPMA re-elects Fred Hassan as president
24 November 2008
J&J subsidiaries ordered to pay $16.6M over Duragesic death
24 November 2008
Ganymed closes 65M-euro financing round
24 November 2008
PharmaZell opens Indian mesalamine facility
24 November 2008
Astellas enters Indian market
24 November 2008
Vernalis hires former Acambis CEO Ian Garland and CFO David Mackney
24 November 2008
Penn to manufacture malaria candidate
24 November 2008
Promising Ph IIa data on Tibotec's HCV drug
24 November 2008
Debiopharm licenses Debio 0617 to Aurigene
24 November 2008
Biovitrum/Symphogen completes proof-of-principle study
24 November 2008
AZ promotes Rich Fante to president of US business
24 November 2008
MedImmune confirms Tony Zook as president
24 November 2008
Grunenthal names J&J's Harald Stock as first-ever CEO
24 November 2008
XTL looking to future after drug fails key trial
24 November 2008
Sequenom acquires Michigan CLIA-lab
24 November 2008
GSK survey calls for more HPV education
24 November 2008
Another PML case for Genentech's Raptiva
24 November 2008
Progenics gets Australian appro for Relistor
24 November 2008
Stock Commentary - New York week to Nov 17, 2008
24 November 2008
Stock Commentary - Europe - week to Nov 17, 2008
24 November 2008
Daschle set to be health "czar" and lead HHS
24 November 2008
Roche, Merck Serono and Abbott in BioRN cluster
24 November 2008
AZ drops 11% as FDA clears Teva's Pulmicort
24 November 2008
Cheap ARVs in India "win-win" for pharma
24 November 2008
IFPMA report on dev world disease R&D
24 November 2008
IFPMA members gave 11% of health aid
24 November 2008
German Cartel Office clears Lilly's buy of ImClone
24 November 2008
Altus to file Trizytek NDA 1st-half 2009
24 November 2008
Life Sci in deal with Abbott to develop Ab 806
24 November 2008
Adolor and GSK publish Ph III Entereg results
24 November 2008
FDA allows Teva's Pulmicort to AZ's protests
24 November 2008
FDA updates on delay for Nordisk's liraglutide
24 November 2008
US FDA approves Mylan's generic Sarafem
24 November 2008
OBM's ProSavin boosts UPDRS up to 50%
24 November 2008
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
